Published: February 04, 2011
AstraZeneca Makes Groundbreaking Gift to La Red Health Center to Expand Health Services in Sussex County
WILMINGTON, Del. - (BUSINESS WIRE) - AstraZeneca
(NYSE: AZN) announced today a $250,000 contribution that will help the La
Red Health Center build a new 15,000-square-foot facility to provide
care to more patients in Sussex County. The announcement was made at a
groundbreaking ceremony in Georgetown, DE.
La Red's new facility will have significantly more space for waiting and
exam rooms and will offer dental care - a new clinical service.
"The La Red Health Center provides an invaluable service to the people
of Sussex County by providing high quality health care regardless of
patients' ability to pay," said David Nicoli, AstraZeneca, vice
president corporate affairs. "This expansion will help La Red connect
more people in the community to much needed care."
La Red provides bilingual, high quality, cost effective, primary and
preventive medical care services to 6,500 patients a year. Many of La
Red's patients are uninsured or underinsured and would otherwise have
difficulty accessing medical care due to financial and other barriers.
The new health care facility will allow La Red to serve as both a
medical - and dental -- home for more Sussex County residents.
"I couldn't be more thrilled to see La Red Health Center's new
ambulatory health care facility's construction underway," Sen. Tom
Carper said. "I commend the strong collaboration between private
organizations and the local and federal government to support the
development of this health care facility. One of the goals of reforming
our nation's health care system is to find ways to get better health
outcomes for less money. A key tactic of reducing health care costs is
to keep people from becoming sick in the first place. La Red's mission
focuses on providing high-quality, cost-effective, primary and
preventive medical care to Sussex County residents who face barriers to
medical care. La Red's new health care facility means more services and
space to help keep Delawareans in Sussex County - both insured and
uninsured, and from every economic level - healthy and out of the
emergency room, lowering costs to our nation's health care system."
AstraZeneca is part of a public-private collaborative effort to support
this expansion of health care services in Sussex County. AstraZeneca's
partnership with La Red Health Center began in 2007 with the launch of Healthy
Delawareans Today & Tomorrow, a public-private coalition aimed
at increasing the awareness and availability of free and low-cost
healthcare services for uninsured and underinsured Delawareans.
AstraZeneca continues to support La Red's patient navigation efforts to
help connect people with the services and programs they need.
"This is an exciting time for La Red Health Center as we enter our
second decade of providing quality health care to the residents of
Sussex County. The new facility will allow La Red to do even more to
increase access to quality and affordable ambulatory medical care and
serve as a medical home for an increased number of Sussex Countians,"
said Brian S. Olson, chief executive officer, La Red Health Center.
"This effort is being made possible through the collective effort of La
Red's many partners. We are particularly appreciative of AstraZeneca's
support for the new building as well as their long-time support."
About La Red Health Center
La Red Health Center's, (LRHC) mission is to provide bilingual,
culturally appropriate, high-quality, cost-effective, primary and
preventive medical care to residents of Sussex County, Delaware with
emphasis towards serving those who are underinsured, uninsured or who
face other barriers to medical care. LRHC's medical services are
available to all individuals regardless of gender, age, race, ethnic
origin, religion, language, sexual orientation or ability to pay.
About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business
with a primary focus on the discovery, development and commercialization
of prescription medicines. As a leader in gastrointestinal,
cardiovascular, neuroscience, respiratory and inflammation, oncology and
infectious disease medicines, AstraZeneca generated global revenues of
$32.8 billion in 2009. In the United States, AstraZeneca is a $14.8
billion healthcare business.
For more information about AstraZeneca in the US or our AZ&Me
Prescription Savings programs, please visit: www.astrazeneca-us.com
or call 1-800-AZandMe (292-6363).

AstraZeneca
Media Inquiries:
Katie Lubenow, 302-885-9960
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News